Status:
COMPLETED
Prophylactic Injection Therapy Reduces Recurrent Bleeding In Forrest Type IIb Duodenal Ulcers
Lead Sponsor:
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Conditions:
Duodenal Ulcer Bleeding
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to determine whether prophylactic injection therapy reduces recurrent bleeding rate for duodenal ulcers which has the endoscopic stigmata of recent bleeding.
Detailed Description
The benefit of endoscopic therapy in ulcers with adherent clots on their surface is still uncertain. A prophylactic injection therapy may reduce the recurrent bleeding rate at this group of patients h...
Eligibility Criteria
Inclusion
- Endoscopic diagnose of Forrest type 2b duodenal ulcer.
Exclusion
- Patients at whom the onset of Upper Gastrointestinal system bleeding symptoms exceeded 24 hours at index endoscopy.
- Patients having hemodynamic instability: systolic blood pressure below 90 mm/hg, heart rate above 110/min
- Demonstration of hemoglobin fall more than 2 g/dl in two hours.
- Patients with coexisting ulcers elsewhere than in duodenum.
- Patients under anticoagulant therapy other than Aspirin.
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01471496
Start Date
January 1 2003
End Date
October 1 2009
Last Update
November 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Department of General Surgery
Istanbul, Turkey (Türkiye), 34147